Heron Therapeutics

NCT07639723

Collaborator, Phase 4, Not yet recruiting, 2026, 350 people, 10 Jun 2026, clinicaltrials.gov

NCT03974932

Phase 3, Completed, 2019, 116 people, 5 Jun 2019, clinicaltrials.gov

NCT02106494

Phase 3, Completed, 2014, 942 people, 8 Apr 2014, clinicaltrials.gov

NCT00343460

Phase 3, Completed, 2006, 1,428 people, 23 Jun 2006, clinicaltrials.gov